Willingness to Accept a COVID-19 Vaccine in Nigeria: A Population-based Cross-sectional Study

Ekaete Alice Tobin; Martha Okonofua; Azuka Adeke; Andrew Obi

doi:doi:10.11648/j.cajph.20210702.12

| Peer-Reviewed

Willingness to Accept a COVID-19 Vaccine in Nigeria: A Population-based Cross-sectional Study

Ekaete Alice Tobin, Martha Okonofua, Azuka Adeke, Andrew Obi

Published in Central African Journal of Public Health (Volume 7, Issue 2)

Received: 22 February 2021 Accepted: 11 March 2021 Published: 26 March 2021

Views: Downloads:

Download PDF

Share This Article

Twitter
Linked In
Facebook

Abstract

Background: The study assessed the intention to accept a future COVID-19 vaccine in Nigeria and associated factors. Materials and Methods: Between July 2020 and August 2020, a cross-sectional study was conducted using an online questionnaire that captured demographic data, risk perception, trust in government and public health authorities and willingness to accept a future COVID-19 vaccine. Data were analyzed using Statistical Package for Social Science version 21.0, Chi-square and logistic regression were carried out at a 95% confidence interval. Appropriate institutional ethical board approval and informed consent were obtained from all participants. Results: 1,228 responses were received over the study period. The mean age of respondents was 32.8 years (SD 10.4), 12.7% (156/1,228) were health workers, 70.1% (861/1,228) had tertiary level of education. Intention to accept a future COVID-19 vaccine was expressed by 50.2% (617/1,228) of respondents. Increasing age, male gender, trust in government, trust in public health authorities, confidence in vaccine developers, willingness to pay for and travel for a vaccine, and vaccination during an outbreak were significantly associated with COVID-19 vaccine acceptance. Healthcare workers and respondents with pre-existing medical conditions were not significantly different from non-healthcare workers and persons without medical conditions respectively with regards to the willingness to be vaccinated. Conclusion: One in two persons would accept a COVID-19 vaccine when it becomes available in the country. The government should take pro-active steps to address the factors that may potentially impact on the benefits expected from the introduction of COVID-19 vaccine and scale-up vaccine sensitization to improve potential acceptance for uptake across the country.

Published in	Central African Journal of Public Health (Volume 7, Issue 2)
DOI	10.11648/j.cajph.20210702.12
Page(s)	53-60
Creative Commons	This is an Open Access article, distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution and reproduction in any medium or format, provided the original work is properly cited.
Copyright	Copyright © The Author(s), 2021. Published by Science Publishing Group

Keywords

COVID-19, Hesitancy, Intention, Vaccine, Willingness

References

[1]	Unal, M. and Irez, T. (2020) COVID 19 Disease Caused by Coronavirus 2 (SARS-CoV-2) (Severe Acute Respiratory Syndrome). Asian Journal of Medicine and Health, 1–11.
[2]	Mahar, I. (2020) Impact of Covid-19 on Global Economy Structure [Internet]. Modern Diplomacy. 2020 [cited 2020 Jun 14]. Available from: https://moderndiplomacy.eu/2020/04/22/impact-of-covid-19-on-global-economy-structure/.
[3]	Olum, R., Chekwech, G., Wekha, G., Nassozi, D. R. and Bongomin, F. (2020) Coronavirus Disease-2019: Knowledge, Attitude, and Practices of Health Care Workers at Makerere University Teaching Hospitals, Uganda. Frontiers in Public Health, Frontiers Media SA. 8. https://doi.org/10.3389/fpubh.2020.00181
[4]	Organisation, W. H. Coronavirus [Internet].
[5]	Neumann-Böhme, S., Nirosha, •, Varghese, E., Sabat, • Iryna, Pedro, •, Barros, P. et al. (2020) Once we have it, will we use it? A European survey on willingness to be vaccinated against COVID-19. The European Journal of Health Economics, 1, 3. https://doi.org/10.1007/s10198-020-01208-6.
[6]	National Bureau of Statitstics. (2018) Nigeria national immunization coverage survey (nics): national brief.
[7]	Jegede, A. S. (2007) What led to the Nigerian boycott of the polio vaccination campaign? PLoS Medicine, Public Library of Science. 4, 417–22. https://doi.org/10.1371/journal.pmed.0040073.
[8]	Harapan, H., Wagner, A. L., Yufika, A., Winardi, W., Anwar, S., Gan, A. K. et al. (2020) Acceptance of a COVID-19 Vaccine in Southeast Asia: A Cross-Sectional Study in Indonesia. Frontiers in Public Health, Frontiers. 8, 381. https://doi.org/10.3389/fpubh.2020.00381.
[9]	Domek, G. J., O’Leary, S. T., Bull, S., Bronsert, M., Contreras-Roldan, I. L., Bolaños Ventura, G. A. et al. (2018) Measuring vaccine hesitancy: Field testing the WHO SAGE Working Group on Vaccine Hesitancy survey tool in Guatemala. Vaccine, Elsevier Ltd. 36, 5273–81. https://doi.org/10.1016/j.vaccine.2018.07.046.
[10]	Ma, X., He, Z., Wang, Y., Jiang, L., Xu, Y., Qian, C. et al. (2011) Knowledge and attitudes of healthcare workers in Chinese intensive care units regarding 2009 H1N1 influenza pandemic. BMC Infectious Diseases, BioMed Central. 11, 1–7. https://doi.org/10.1186/1471-2334-11-24.
[11]	Barello, S., Nania, T., Dellafiore, F., Graffigna, G. and Caruso, R. (2020) ‘Vaccine hesitancy’ among university students in Italy during the COVID-19 pandemic. European Journal of Epidemiology, Springer. 1, 1. https://doi.org/10.1007/s10654-020-00670-z.
[12]	Sun, S. (2020) Interest in COVID-19 vaccine trials participation among young adults in China: Willingness, reasons for hesitancy, and demographic and psychosocial determinants. Med Rxiv: the preprint server for health sciences, 2020.07.13.20152678. https://doi.org/10.1101/2020.07.13.20152678.
[13]	Dodd, R. H., Cvejic, E., Bonner, C., Pickles, K. and Mccaffery, K. J. (2014) Willingness to vaccinate against COVID-19 in Australia. BMC Public Health, 14, 484. https://doi.org/10.1016/S1473-3099(20)30559-4.
[14]	Malik, A. A., McFadden, S. M., Elharake, J. and Omer, S. B. (2020) Determinants of COVID-19 vaccine acceptance in the US. EClinical Medicine, Elsevier. 0, 100495. https://doi.org/10.1016/j.eclinm.2020.100495.
[15]	Malesza, M. (2020) Acceptability of COVID-19 vaccination during pandemic phase of coronavirus in Poland: population-based cross-sectional survey.
[16]	Magadmi, R. and Kamel, F. (2020) Beliefs and Barriers Associated with COVID-19 Vaccination Among the General Population in Saudi Arabia. Research Square.
[17]	Detoc, M., Bruel, S., Frappe, P., Botelho-Nevers, E. and Gagneux-Brunon, A. (2020) Intention to participate in a COVID-19 vaccine clinical trial and to get vaccinated against COVID-19 in France during the pandemic. MedRxiv, 2020.04.23.20076513. https://doi.org/10.1101/2020.04.23.20076513.
[18]	Fu, C., Wei, Z., Pei, S., Li, S., Sun, X. and Liu, P. (2020) Acceptance and preference for COVID-19 vaccination in health-care workers (HCWs). https://doi.org/10.1101/2020.04.09.20060103.
[19]	Padhi, B. K. and A. Almohaithef, M. (2020) Determinants of intent to uptake Coronavirus vaccination among respondents in Saudi Arabia: a web-based national survey. MedRxiv, 2020.05.27.20114413. https://doi.org/10.1101/2020.05.27.20114413.
[20]	Omaka-Amari, L., Aleke, A., Obande-Ogbuinya, N., Ngwakwe, P., Nwankwo, O. and Afoke, E. (2020) Coronavirus (COVID-19) Pandemic in Nigeria: Preventive and Control Challenges within the First Two Months of Outbreak. African Journal of Reproductive Health, 24, 87–97.
[21]	Adekunle, A. I., Adegboye, O. A., Gayawan, E. and McBryde, E. S. (2020) Is Nigeria really on top of COVID-19? Message from effective reproduction number. Epidemiology and Infection, NLM (Medline). 148, e166. https://doi.org/10.1017/S0950268820001740.

Cite This Article

Plain Text BibTeX RIS

APA Style

Ekaete Alice Tobin, Martha Okonofua, Azuka Adeke, Andrew Obi. (2021). Willingness to Accept a COVID-19 Vaccine in Nigeria: A Population-based Cross-sectional Study. Central African Journal of Public Health, 7(2), 53-60. https://doi.org/10.11648/j.cajph.20210702.12

Copy | Download

ACS Style

Ekaete Alice Tobin; Martha Okonofua; Azuka Adeke; Andrew Obi. Willingness to Accept a COVID-19 Vaccine in Nigeria: A Population-based Cross-sectional Study. Cent. Afr. J. Public Health 2021, 7(2), 53-60. doi: 10.11648/j.cajph.20210702.12

Copy | Download

AMA Style

Ekaete Alice Tobin, Martha Okonofua, Azuka Adeke, Andrew Obi. Willingness to Accept a COVID-19 Vaccine in Nigeria: A Population-based Cross-sectional Study. Cent Afr J Public Health. 2021;7(2):53-60. doi: 10.11648/j.cajph.20210702.12

Copy | Download

@article{10.11648/j.cajph.20210702.12,
  author = {Ekaete Alice Tobin and Martha Okonofua and Azuka Adeke and Andrew Obi},
  title = {Willingness to Accept a COVID-19 Vaccine in Nigeria: A Population-based Cross-sectional Study},
  journal = {Central African Journal of Public Health},
  volume = {7},
  number = {2},
  pages = {53-60},
  doi = {10.11648/j.cajph.20210702.12},
  url = {https://doi.org/10.11648/j.cajph.20210702.12},
  eprint = {https://article.sciencepublishinggroup.com/pdf/10.11648.j.cajph.20210702.12},
  abstract = {Background: The study assessed the intention to accept a future COVID-19 vaccine in Nigeria and associated factors. Materials and Methods: Between July 2020 and August 2020, a cross-sectional study was conducted using an online questionnaire that captured demographic data, risk perception, trust in government and public health authorities and willingness to accept a future COVID-19 vaccine. Data were analyzed using Statistical Package for Social Science version 21.0, Chi-square and logistic regression were carried out at a 95% confidence interval. Appropriate institutional ethical board approval and informed consent were obtained from all participants. Results: 1,228 responses were received over the study period. The mean age of respondents was 32.8 years (SD 10.4), 12.7% (156/1,228) were health workers, 70.1% (861/1,228) had tertiary level of education. Intention to accept a future COVID-19 vaccine was expressed by 50.2% (617/1,228) of respondents. Increasing age, male gender, trust in government, trust in public health authorities, confidence in vaccine developers, willingness to pay for and travel for a vaccine, and vaccination during an outbreak were significantly associated with COVID-19 vaccine acceptance. Healthcare workers and respondents with pre-existing medical conditions were not significantly different from non-healthcare workers and persons without medical conditions respectively with regards to the willingness to be vaccinated. Conclusion: One in two persons would accept a COVID-19 vaccine when it becomes available in the country. The government should take pro-active steps to address the factors that may potentially impact on the benefits expected from the introduction of COVID-19 vaccine and scale-up vaccine sensitization to improve potential acceptance for uptake across the country.},
 year = {2021}
}

Copy | Download

TY  - JOUR
T1  - Willingness to Accept a COVID-19 Vaccine in Nigeria: A Population-based Cross-sectional Study
AU  - Ekaete Alice Tobin
AU  - Martha Okonofua
AU  - Azuka Adeke
AU  - Andrew Obi
Y1  - 2021/03/26
PY  - 2021
N1  - https://doi.org/10.11648/j.cajph.20210702.12
DO  - 10.11648/j.cajph.20210702.12
T2  - Central African Journal of Public Health
JF  - Central African Journal of Public Health
JO  - Central African Journal of Public Health
SP  - 53
EP  - 60
PB  - Science Publishing Group
SN  - 2575-5781
UR  - https://doi.org/10.11648/j.cajph.20210702.12
AB  - Background: The study assessed the intention to accept a future COVID-19 vaccine in Nigeria and associated factors. Materials and Methods: Between July 2020 and August 2020, a cross-sectional study was conducted using an online questionnaire that captured demographic data, risk perception, trust in government and public health authorities and willingness to accept a future COVID-19 vaccine. Data were analyzed using Statistical Package for Social Science version 21.0, Chi-square and logistic regression were carried out at a 95% confidence interval. Appropriate institutional ethical board approval and informed consent were obtained from all participants. Results: 1,228 responses were received over the study period. The mean age of respondents was 32.8 years (SD 10.4), 12.7% (156/1,228) were health workers, 70.1% (861/1,228) had tertiary level of education. Intention to accept a future COVID-19 vaccine was expressed by 50.2% (617/1,228) of respondents. Increasing age, male gender, trust in government, trust in public health authorities, confidence in vaccine developers, willingness to pay for and travel for a vaccine, and vaccination during an outbreak were significantly associated with COVID-19 vaccine acceptance. Healthcare workers and respondents with pre-existing medical conditions were not significantly different from non-healthcare workers and persons without medical conditions respectively with regards to the willingness to be vaccinated. Conclusion: One in two persons would accept a COVID-19 vaccine when it becomes available in the country. The government should take pro-active steps to address the factors that may potentially impact on the benefits expected from the introduction of COVID-19 vaccine and scale-up vaccine sensitization to improve potential acceptance for uptake across the country.
VL  - 7
IS  - 2
ER  -

Copy | Download

Author Information

Ekaete Alice Tobin

Institute of Lassa Fever Research and Control, Irrua Specialist Teaching Hospital, Irrua, Nigeria
Martha Okonofua

Institute of Lassa Fever Research and Control, Irrua Specialist Teaching Hospital, Irrua, Nigeria
Azuka Adeke

Department of Community Medicine, Alex Ekwueme Federal University Teaching Hospital, Abakaliki, Nigeria
Andrew Obi

Department of Community Health, University of Benin, Benin-city, Nigeria

Download PDF

Sections

Plain Text BibTeX RIS

APA Style

Ekaete Alice Tobin, Martha Okonofua, Azuka Adeke, Andrew Obi. (2021). Willingness to Accept a COVID-19 Vaccine in Nigeria: A Population-based Cross-sectional Study. Central African Journal of Public Health, 7(2), 53-60. https://doi.org/10.11648/j.cajph.20210702.12

Copy | Download

ACS Style

Ekaete Alice Tobin; Martha Okonofua; Azuka Adeke; Andrew Obi. Willingness to Accept a COVID-19 Vaccine in Nigeria: A Population-based Cross-sectional Study. Cent. Afr. J. Public Health 2021, 7(2), 53-60. doi: 10.11648/j.cajph.20210702.12

Copy | Download

AMA Style

Ekaete Alice Tobin, Martha Okonofua, Azuka Adeke, Andrew Obi. Willingness to Accept a COVID-19 Vaccine in Nigeria: A Population-based Cross-sectional Study. Cent Afr J Public Health. 2021;7(2):53-60. doi: 10.11648/j.cajph.20210702.12

Copy | Download

@article{10.11648/j.cajph.20210702.12,
  author = {Ekaete Alice Tobin and Martha Okonofua and Azuka Adeke and Andrew Obi},
  title = {Willingness to Accept a COVID-19 Vaccine in Nigeria: A Population-based Cross-sectional Study},
  journal = {Central African Journal of Public Health},
  volume = {7},
  number = {2},
  pages = {53-60},
  doi = {10.11648/j.cajph.20210702.12},
  url = {https://doi.org/10.11648/j.cajph.20210702.12},
  eprint = {https://article.sciencepublishinggroup.com/pdf/10.11648.j.cajph.20210702.12},
  abstract = {Background: The study assessed the intention to accept a future COVID-19 vaccine in Nigeria and associated factors. Materials and Methods: Between July 2020 and August 2020, a cross-sectional study was conducted using an online questionnaire that captured demographic data, risk perception, trust in government and public health authorities and willingness to accept a future COVID-19 vaccine. Data were analyzed using Statistical Package for Social Science version 21.0, Chi-square and logistic regression were carried out at a 95% confidence interval. Appropriate institutional ethical board approval and informed consent were obtained from all participants. Results: 1,228 responses were received over the study period. The mean age of respondents was 32.8 years (SD 10.4), 12.7% (156/1,228) were health workers, 70.1% (861/1,228) had tertiary level of education. Intention to accept a future COVID-19 vaccine was expressed by 50.2% (617/1,228) of respondents. Increasing age, male gender, trust in government, trust in public health authorities, confidence in vaccine developers, willingness to pay for and travel for a vaccine, and vaccination during an outbreak were significantly associated with COVID-19 vaccine acceptance. Healthcare workers and respondents with pre-existing medical conditions were not significantly different from non-healthcare workers and persons without medical conditions respectively with regards to the willingness to be vaccinated. Conclusion: One in two persons would accept a COVID-19 vaccine when it becomes available in the country. The government should take pro-active steps to address the factors that may potentially impact on the benefits expected from the introduction of COVID-19 vaccine and scale-up vaccine sensitization to improve potential acceptance for uptake across the country.},
 year = {2021}
}

Copy | Download

TY  - JOUR
T1  - Willingness to Accept a COVID-19 Vaccine in Nigeria: A Population-based Cross-sectional Study
AU  - Ekaete Alice Tobin
AU  - Martha Okonofua
AU  - Azuka Adeke
AU  - Andrew Obi
Y1  - 2021/03/26
PY  - 2021
N1  - https://doi.org/10.11648/j.cajph.20210702.12
DO  - 10.11648/j.cajph.20210702.12
T2  - Central African Journal of Public Health
JF  - Central African Journal of Public Health
JO  - Central African Journal of Public Health
SP  - 53
EP  - 60
PB  - Science Publishing Group
SN  - 2575-5781
UR  - https://doi.org/10.11648/j.cajph.20210702.12
AB  - Background: The study assessed the intention to accept a future COVID-19 vaccine in Nigeria and associated factors. Materials and Methods: Between July 2020 and August 2020, a cross-sectional study was conducted using an online questionnaire that captured demographic data, risk perception, trust in government and public health authorities and willingness to accept a future COVID-19 vaccine. Data were analyzed using Statistical Package for Social Science version 21.0, Chi-square and logistic regression were carried out at a 95% confidence interval. Appropriate institutional ethical board approval and informed consent were obtained from all participants. Results: 1,228 responses were received over the study period. The mean age of respondents was 32.8 years (SD 10.4), 12.7% (156/1,228) were health workers, 70.1% (861/1,228) had tertiary level of education. Intention to accept a future COVID-19 vaccine was expressed by 50.2% (617/1,228) of respondents. Increasing age, male gender, trust in government, trust in public health authorities, confidence in vaccine developers, willingness to pay for and travel for a vaccine, and vaccination during an outbreak were significantly associated with COVID-19 vaccine acceptance. Healthcare workers and respondents with pre-existing medical conditions were not significantly different from non-healthcare workers and persons without medical conditions respectively with regards to the willingness to be vaccinated. Conclusion: One in two persons would accept a COVID-19 vaccine when it becomes available in the country. The government should take pro-active steps to address the factors that may potentially impact on the benefits expected from the introduction of COVID-19 vaccine and scale-up vaccine sensitization to improve potential acceptance for uptake across the country.
VL  - 7
IS  - 2
ER  -

Copy | Download